Highland Capital Management (Texas)’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$707K	Hold	16,250	–	–	0.04%	233
2019 Q1	$618K	Buy	16,250 +7,500	+86%	+$293K	0.04%	234
2018 Q4	$376K	Hold	8,750	–	–	0.03%	215
2018 Q3	$430K	Buy	+8,750	New	+$378K	0.02%	242
2017 Q3	–	Sell	-67,000	Closed	-$3.2M	–	335
2017 Q2	$3.2M	Sell	67,000 -29,000	-30%	-$1.35M	0.14%	117
2017 Q1	$4.38M	Buy	96,000 +25,321	+36%	+$1.09M	0.22%	104
2016 Q4	$2.28M	Sell	70,679 -57,700	-45%	-$1.93M	0.11%	136
2016 Q3	$4.39M	Buy	128,379 +29,179	+29%	+$1.14M	0.13%	136
2016 Q2	$3.35M	Buy	99,200 +26,502	+36%	+$1.3M	0.14%	137
2016 Q1	$3.85M	Buy	+72,698	New	+$4.25M	0.17%	136
2015 Q4	–	Sell	-242,455	Closed	-$9.96M	–	279
2015 Q3	$9.96M	Buy	+242,455	New	+$14.9M	0.29%	98
2015 Q1	–	Sell	-29,573	Closed	-$2.62M	–	247
2014 Q4	$2.62M	Sell	29,573 -6,623	-18%	-$626K	0.09%	125
2014 Q3	$3.51M	Buy	+36,196	New	+$3.52M	0.13%	127